missing translation for 'onlineSavingsMsg'
Learn More

EGLN2 Monoclonal Antibody (OTI5E11), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA808685

Encompass_Preferred

 View more versions of this product

Product Code. 17580184

  • € 540.87 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

The hypoxia inducible factor (HIF) is a transcriptional complex which is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this posttranslational modification. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Specifications

Specifications

EGLN2
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Q96KS0
EGLN2
Full length human recombit protein of human EGLN2 produced in E.coli.
100 μL
Primary
Human
Antibody
IgG1
Western Blot
OTI5E11
Unconjugated
EGLN2
EIT6, HIF-PH1, HIFPH1, HPH-1, HPH-3, PHD1
Mouse
Affinity Chromatography
RUO
112398
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.